We cannot exclude the possibility that increased NNMT activity in the liver of patients with type 2 diabetes and obesity may, in addition to increased expression in WAT, also contribute to the observed associations in these patients. This evidence concerns the gene NNMT and obesity due to melanocortin 4 receptor deficiency.